News stories about Imperva (NYSE:IMPV) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Imperva earned a coverage optimism score of 0.18 on Accern’s scale. Accern also gave media stories about the software maker an impact score of 46.8138495817307 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

IMPV has been the subject of a number of analyst reports. Evercore ISI restated a “buy” rating and set a $56.00 price objective on shares of Imperva in a research report on Friday, May 5th. Monness Crespi & Hardt upped their price objective on shares of Imperva from $52.00 to $55.00 and gave the stock a “buy” rating in a research report on Friday, May 5th. Royal Bank Of Canada upped their price objective on shares of Imperva from $52.00 to $55.00 and gave the stock an “outperform” rating in a research report on Friday, May 5th. TheStreet upgraded shares of Imperva from a “d” rating to a “c” rating in a research report on Thursday, May 4th. Finally, Imperial Capital restated an “outperform” rating and set a $57.00 price objective (up previously from $55.00) on shares of Imperva in a research report on Tuesday, May 9th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. Imperva presently has an average rating of “Buy” and an average price target of $51.25.

Shares of Imperva (NYSE IMPV) traded up 1.75% on Friday, hitting $43.60. 730,246 shares of the stock traded hands. Imperva has a one year low of $34.40 and a one year high of $57.24. The stock’s market cap is $1.47 billion. The company’s 50 day moving average is $47.61 and its 200 day moving average is $45.32.

Imperva (NYSE:IMPV) last issued its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.05 by $0.15. The company had revenue of $74.44 million during the quarter, compared to analysts’ expectations of $74.30 million. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The company’s revenue for the quarter was up 28.6% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.23) EPS. On average, equities analysts forecast that Imperva will post $0.81 EPS for the current year.

In other Imperva news, insider Amichai Shulman sold 3,089 shares of Imperva stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $48.70, for a total transaction of $150,434.30. Following the transaction, the insider now owns 100,151 shares of the company’s stock, valued at approximately $4,877,353.70. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Sunil D. Nagdev sold 4,857 shares of Imperva stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $49.00, for a total value of $237,993.00. Following the transaction, the senior vice president now directly owns 16,290 shares in the company, valued at approximately $798,210. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This report was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.watchlistnews.com/imperva-nyseimpv-earning-somewhat-favorable-press-coverage-analysis-finds/1480166.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Insider Buying and Selling by Quarter for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.